Navigation Links
Drug Meant to Heal Turns ‘heel’ and Hars

In a case of a therapeutic drug turning deadly, hundred of persons have been infected with Hepatitis C.//

Chinese officials from the ministry of heath have ordered the recall of samples of the blood-based drug used in the treatment of immune system deficiencies.

The drug manufactured by Guangdong Bioyee Pharmaceutical Co. Ltd., is extracted from human blood and injected intravenously during treatment.

China's Health Ministry and drug watchdog, the State Food and Drug Administration, said that the Guangdong Bioyee Pharmaceutical Co. Ltd. had committed "illegal behavior" in the production of its immunoglobulin drug and that users had tested positive to "Hepatitis C antibodies".

Officials have recalled around 90,000 doses of the drug and ordered the cessation of its production and sale.

Hepatitis C can lead to chronic liver infection and cirrhosis. About 1 percent to 5 percent of people with the disease eventually die from long-term infection, according to the U.S. Centers for Disease Control and Prevention.

The Health News, a newspaper run by China's Health Ministry, quoted experts as saying that the plasma used to make the immunoglobulin drug might have contained either the hepatitis C virus or its antibodies.

It would take two to eight weeks to rule out the chance of hepatitis C infections for the users, the newspaper said.

The reports did not say how many users the drug had affected or how many samples of the drug were problematic.

Doctor Jia Jidong, from Beijing Friendship Hospital, says not everyone with hepatitis C antibodies in their blood have will fall ill with the diseases.

He estimates that about 50 to 85 percent of those tested positive for antibodies will end up contracting the disease and it can take up to eight weeks before symptoms appear.

Fake or tainted drugs have killed dozens in China in recent years and sparked public fury about drug safety.

The Chinese media puts the blame on businesses chasing profits and on complacent official supervision.


ANN
'"/>




Related medicine news :

1. An Enzyme That Turns a One –time Experience into a long-time Memor
2. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
3. Allergy Alarm: Sams Choice Milk Chocolate Turns Bitter with Undisclosed Nuts
4. Where Mothers Skin Turns Into Food For Offspring
5. A Worm Turns: Banking on Blood From a Little Lugworm
6. Toy Story Turns Bitter-Christmas Toys, No Music to the Ears!
7. Leukemia Drug Turns Mini-Molecules Up, Cancer Genes Down
8. Well-known Kerala Actor, Mohanlal, Turns AIDS Activist
9. Fashion Fraternity Turns Socially Conscious
10. Friend’s Love Turns Out to Be Gay Admiratio
11. Super Bug Turns Super Killer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a ... solutions, today announced that Kyle Allain has joined the company as Vice President ... and operations, including provider, payor and managed care solutions. , A seasoned ...
(Date:4/24/2017)... ... April 24, 2017 , ... In 2017, ... diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into precision ... type of healthcare model in the diagnosis and treatment of brain tumors. Healthcare ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant Management ... , Rod has been at the forefront of Gardant since it was founded in ... has overseen the opening of more than 40 new senior living communities. With his ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her timeless ... news for single women is that she put all the words in her new ... Joan's insight, personal experiences and sparkling sense of humor have inspired her to write ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs ... makes it difficult for lab operators and management to assess these processes with ... identify wasteful or unnecessary actions. , Created with the help of both ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 24, 2017 Solentim, the developer of ... addition of a major new product line called ... The VIPS has been developed for automatically seeding ... as part of the process to generate clonally-derived ... and more reliable solution when compared to traditional ...
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... WARSAW, Ind. , April 20, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Health Care Conference at the InterContinental Hotel in ... 2017.  Zimmer Biomet will present at 11:20 a.m. Eastern ... can be accessed via Zimmer Biomet,s Investor Relations website ...
Breaking Medicine Technology: